Polaryx Therapeutics, Inc. (PLYX) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $5.00K; Additional Paid in CapitalUSD $114.49M; Retained Earnings (Accumulated Deficit)USD $-103.56M; Stockholders' Equity Attributable to ParentUSD $10.94M.
- 2026-03-31: Common Stock, Value, IssuedUSD $5.00K; Additional Paid in CapitalUSD $104.66M; Retained Earnings (Accumulated Deficit)USD $-102.18M; Stockholders' Equity Attributable to ParentUSD $2.49M.
- 2025-12-31: Common Stock, Value, IssuedUSD $5.00K; Additional Paid in CapitalUSD $104.19M; Retained Earnings (Accumulated Deficit)USD $-99.64M; Stockholders' Equity Attributable to ParentUSD $4.57M.
- 2025-06-30: Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD (m); Retained Earnings (Accumulated Deficit)USD (m); Stockholders' Equity Attributable to ParentUSD $3.25M.
Polaryx Therapeutics, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|
| 2026-06-30 | $5.00K | $114.49M | $-103.56M | $10.94M | 6 month · $467.00K |
| 2026-03-31 | $5.00K | $104.66M | $-102.18M | $2.49M | 3 month · $467.00K |
| 2025-12-31 | $5.00K | $104.19M | $-99.64M | $4.57M | (m) |
| 2025-06-30 | (m) | (m) | (m) | $3.25M | (m) |
| 2025-03-31 | (m) | (m) | (m) | $4.25M | (m) |
| 2024-12-31 | $4.00K | $95.36M | $-90.65M | $4.71M | (m) |
| 2023-12-31 | (m) | (m) | (m) | $1.28M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |